Evidence map›Paper›PMID 38051000›Full record

ArticleJournal of materials chemistry. B2023

Surface-segregating zwitterionic copolymers to control poly(dimethylsiloxane) surface chemistry.

A Aslihan Gokaltun, Luca Mazzaferro, Martin L Yarmush, O Berk Usta, Ayse Asatekin

Abstract read
In one paragraph

Article in Journal of materials chemistry. B, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Evaluating the Structural Response of Amphiphilic Monolayers to Environmental Stimuli.Langmuir : the ACS journal of surfaces and colloids · 2025
    Article
  3. Antifouling Zwitterionic Polymer Coatings for Blood-Bearing Medical Devices.Langmuir : the ACS journal of surfaces and colloids · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

A Aslihan GokaltunCenter for Engineering in Medicine and Surgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St., Boston, MA, 02114, USA. ousta@mgh.harvard.edu.ORCID 0000-0002-5880-0049
Luca MazzaferroDepartment of Chemical and Biological Engineering, Tufts University, 4 Colby St., Medford, MA, 02155, USA. Ayse.Asatekin@tufts.edu.
Martin L YarmushCenter for Engineering in Medicine and Surgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St., Boston, MA, 02114, USA. ousta@mgh.harvard.edu.
O Berk UstaCenter for Engineering in Medicine and Surgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St., Boston, MA, 02114, USA. ousta@mgh.harvard.edu.ORCID 0000-0001-9328-568X
Ayse AsatekinDepartment of Chemical and Biological Engineering, Tufts University, 4 Colby St., Medford, MA, 02155, USA. Ayse.Asatekin@tufts.edu.ORCID 0000-0002-4704-1542

Funding

On Demand Dissoluble Supramolecular Hydrogels: Towards Pain Free Burn DressingsR01AR081529 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI Ayse Asatekin, Osman Berk USTA · 2023 to 2026
$1.9M
Deep Supercooling of Red Blood Cells: Towards Practical Long Term StorageR01HL145031 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI USTA, OSMAN BERK, YARMUSH, MARTIN L · 2020 to 2023
$1.5M
Novel Microfluidic Platforms for Actively Controlled in-vitro Liver ZonationR21EB020192 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI USTA, OSMAN BERK · 2015 to 2016
$479k
Deep Supercooling of Liver Cells and 2D and 3D Tissue Constructs: Effect of AttachmentR21GM136002 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI USTA, OSMAN BERK · 2019 to 2020
$462k
Controlling biomicrofluidic device surface chemistry using smart surface-segregating zwitterionic polymersR21GM141683 · NIGMS · TUFTS UNIVERSITY MEDFORD · PI ASATEKIN, AYSE, USTA, OSMAN BERK · 2021 to 2022
$450k
A Novel DExH-box Helicase associates with catalytic editing proteins in a putativR21AI081529 · NIAID · TEXAS A&M UNIVERSITY · PI CRUZ-REYES, JORGE · 2009 to 2010
$388k
NHLBI NIH HHS R01 HL145031NIAID NIH HHS R21 AI081529NIAMS NIH HHS R01 AR081529NIBIB NIH HHS R21 EB020192NIGMS NIH HHS R21 GM136002NIGMS NIH HHS R21 GM141683
6 · The paper itself

Abstract

The use of microfluidic devices in biomedicine is growing rapidly in applications such as organs-on-chip and separations. Polydimethylsiloxane (PDMS) is the most popular material for microfluidics due to its ability to replicate features down to the nanoscale, flexibility, gas permeability, and low cost. However, the inherent hydrophobicity of PDMS leads to the adsorption of macromolecules and small molecules on device surfaces. This curtails its use in "organs-on-chip" and other applications. Current technologies to improve PDMS surface hydrophilicity and fouling resistance involve added processing steps or do not create surfaces that remain hydrophilic for long periods. This work describes a novel, simple, fast, and scalable method for improving surface hydrophilicity and preventing the nonspecific adsorption of proteins and small molecules on PDMS through the use of a surface-segregating zwitterionic copolymer as an additive that is blended in during manufacture. These highly branched copolymers spontaneously segregate to surfaces and rearrange in contact with aqueous solutions to resist nonspecific adsorption. We report that mixing a minute amount (0.025 wt%) of the zwitterionic copolymer in PDMS considerably reduces hydrophobicity and nonspecific adsorption of proteins (albumin and lysozyme) and small molecules (vitamin B12 and reactive red). PDMS blended with these zwitterionic copolymers retains its mechanical and physical properties for at least six months. Moreover, this approach is fully compatible with existing PDMS device manufacture protocols without additional processing steps and thus provides a low-cost and user-friendly approach to fabricating reliable biomicrofluidics.

Indexed as

DimethylpolysiloxanesProteinsMicrofluidicsSurface PropertiesbaysilonDimethylpolysiloxanesProteins

Identifiers

PMID38051000
PMCPMC10777474

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.